baber/WOPTO huggingface dataset:
Patent WO-2023164738-A1 (WO)
Inventor: BORG BRAEDEN
IPC: G01V1/22
Filed: 2022-11-24
Abstract: Embodiments relate to data acquisition units or nodes and more specifically to seismic data acquisition units or nodes for use in data gathering for ambient noise tomography (ANT). Some embodiments relate to a method for data acquisition, and systems employing one or more data acquisition units. Some embodiments relate to systems comprising one or more satellites in communication with one or more data acquisition units for communication to a remote server, for remote storage, and processing for creating sub-surface tomography images accessible to client devices.
Patent WO-2023102618-A1 (WO)
Title: Dispositif de distribution pour liquides dans sac contenant du liquide
Inventor: SZYMANSKI MAREK
IPC: B65B69/00
Filed: 2022-12-09
Abstract: L'invention concerne un dispositif de distribution (10) comprenant une base (12) avec un support vertical (14) contenant un ensemble piston (16) et un support de sac contenant du liquide (22). Le support de sac (22) contient un sac contenant du liquide (20) dont la partie de sortie (94) est supportée sous l'ensemble piston (16). L'ensemble piston (16) est disposé à l'intérieur d'un boîtier (18) comportant une paroi gauche (24), une paroi droite (26) et une partie inférieure ouverte (28). Le support de sac (22) est disposé le long d'une surface externe de la paroi gauche (24). L'ensemble piston (16) comprend un élément presseur (32) monté sur un piston (30). Le piston (30) est déplacé dans l'axe vertical dans un mouvement de va-et-vient linéaire. La rotation de l'arbre du moteur (38) se traduit par un mouvement de va-et-vient du piston (30) vers le haut et vers le bas, ce qui entraîne le déplacement de l'élément presseur (32).
Patent AU-2022201290-A1 (AU)
Title: Compositions and methods for treating renal failure
Inventor: TIDMARSH GEORGE
IPC: A61P1/16
Filed: 2022-02-25
Abstract: The present disclosure relates to the use of angiotensin II in therapeutic methods for the 
treatment of renal failure, especially renal failure associated with cirrhosis.
Patent AU-2022201316-A1 (AU)
Title: Device architecture
Inventor: SNAITH HENRY JAMES
IPC: H01L51/44
Filed: 2022-02-25
Abstract: The present invention relates to an optoelectronic device comprising: (a) a 
substrate comprising at least one first electrode, which at least one first electrode 
comprises a first electrode material, and at least one second electrode, which at 
least one second electrode comprises a second electrode material; and (b) a 
photoactive material disposed on the substrate, which photoactive material is in 
contact with the at least one first electrode and the at least one second electrode, 
wherein the substrate comprises: a layer of the first electrode material; and, 
disposed on the layer of the first electrode material, a layer of an insulating 
material, which layer of an insulating material partially covers the layer of the 
first electrode material; and, disposed on the layer of the insulating material, the 
second electrode material, and wherein the photoactive material comprises a 
crystalline compound, which crystalline compound comprises: one or more first 
cations selected from metal or metalloid cations; one or more second cations 
selected from Cs*, Rb+, K+, NH 4 and organic cations; and one or more halide or 
chalcogenide anions. A substrate comprising a first and second electrode and 
processes are also described
Patent AU-2022201346-A1 (AU)
Title: Pharmaceutical composition for prevention and/or treatment of atopic dermatitis containing IL-31 antagonist as active ingredient
Inventor: KANEKO AKIHISA
IPC: A61P17/00
Filed: 2022-02-26
Abstract: In a non-limiting embodiment, there is provided a pharmaceutical composition for 
prevention and/or treatment of atopic dermatitis comprising an IL-31 antagonist as an active 
ingredient, wherein the IL-31 antagonist is repeatedly administered in equal amounts at the same 
dosing interval to a subject with or potentially with atopic dermatitis, at 0.1 to 1000 mg/body/I 
day to 12 weeks, preferably at 0.1 to 1000 mg/body/2 weeks, 0.1 to 1000 mg/body/4 weeks, or 
0.1 to 1000 mg/body/8 weeks.
Patent AU-2022201876-A1 (AU)
Title: Cross channel lottery game promotion
Inventor: WENZL BERND
IPC: G07F17/32
Filed: 2022-03-18
Abstract: OF THE DISCLOSURE 
A system configured to receive a triggering event occurrence message based on 
an occurrence of a lottery game promotional message triggering event in association with 
an electronic gaming machine and a player mobile device of a player, determine whether 
to communicate a lottery game promotional message to the player mobile device, use 
player data, player mobile device data, and lottery game data to create the lottery game 
promotional message, and communicate the lottery game promotional message to the 
player mobile device.
Sheet 3of7 
cu 
4-0
C U)O U) O -~ ,L CC (D -c CD -u 0 U I 
I 
0u<-f Oc C -0 
CuD 
0 cu 
LL)) Q) (D 
Coo _u 4 L 
C)C CD 
QCU 
a) D a 
2!~ E 0)a
Patent AU-2022202256-A1 (AU)
Title: N-terminal epitopes in Amyloid beta and conformationally-selective antibodies thereto
Inventor: CASHMAN NEIL R
IPC: A61K39/385
Filed: 2022-04-05
Abstract: The disclosure pertains to N-terminal epitopes identified in A-beta, including conformational epitopes, 
antibodies thereto and methods of making and using immunogens and antibodies specific thereto.  
5
Patent AU-2022204013-A1 (AU)
Title: Targeted delivery of tertiary amine-containing drug substances
Inventor: BURKE PATRICK J
IPC: A61K45/06
Filed: 2022-06-09
Abstract: TARGETED DELIVERY OF TERTIARY AMINE-CONTAINING DRUG 
SUBSTANCES 
Abstract 
L54cy Hodgkin lymphoma xenograft, ADCs loaded at 4 drugslAb 
9 -untreated 
1000. -9- cAC1O-C, 1mg/kg 
S-0- cAC10-C, 2 mglkg 
0( hO-C, 2 mglkg 
500. - cAC10-14, 1 mg/kg 
E -&- cACTO-14, 2 mglkg 
,h00-14,2 mgtkg 
E 0o 
0 20 40 0 80 100 
days post implant 
FIGURE I 
Compounds and compositions are disclosed in which a quaternized drug unit 
is linked to a targeting ligand unit from which a tertiary amine-containing drug is 
released at the targeted site of action. Methods for treating diseases characterized by 
the targeted abnormal cells, such as cancer or an autoimmune disease using the 
compounds and compositions of the invention are also disclosed.
Patent AU-2022208268-A1 (AU)
Title: A transportation tray for transportation of a filled syringe
Inventor: HANG TIANQI
IPC: A61M5/00
Filed: 2022-01-12
Abstract: A transportation tray to transport filled syringes, the tray including a front shelf spaced apart from a rear shelf, with the front shelf and the rear shelf being on approximately the same plane. The front shelf includes at least one set of paired flexible fingers, the paired flexible fingers being spaced apart sufficiently to accommodate a barrel of a syringe and to thus hold the syringe on the tray.
Patent AU-2022209708-A1 (AU)
Title: Systems and methods for completing a remote lottery ticket sales transaction via receiving payment at a point of sale
Inventor: GOTLIEB RICHARD A
IPC: G06Q50/34
Filed: 2022-01-21
Abstract: Systems and methods for completing a transaction request via receiving payment at a point of sale comprising: a lottery ticket provider, wherein the lottery ticket provider is remote from an originating location of the transaction request and wherein the lottery ticket provider comprises: a processing device; a user device; a fulfillment computer device; a lottery ticket; and a lottery ticket approved sales location database.
Patent AU-2022218580-A1 (AU)
Title: Liquid dispenser with manifold mount for modular independently-actuated pipette channels
Inventor: SHEDLOSKY ALYSSA
IPC: G01N1/18
Filed: 2022-08-18
Abstract: Automated pipetting systems and methods are disclosed for aspirating and dispensing fluids, 
particularly biological samples. In one aspect, a liquid dispenser includes a manifold and one 
or more pipette channels. The manifold includes a vacuum channel, a pressure channel, and a 
plurality of lanes. Each lane includes an electrical connector, a port to the pressure channel, 
and a port to the vacuum channel. The pipette channels can be modular. Each pipette channel 
includes a single dispense head and can be selectively and independently coupled to any one 
lane of the plurality of lanes. In some aspects, a valve in the pipette channel is in simultaneous 
fluid communication with a pressure port and a vacuum port of the manifold. The valve 
selectively diverts gas under pressure and gas under vacuum to the dispense head in response 
to control signals received through the electrical connector of the manifold.
Patent AU-2022232622-A1 (AU)
Title: Strategies for knock-ins at c3 safe harbor sites
Inventor: EMMANUEL RAFI
IPC: A61K48/00
Filed: 2022-03-10
Abstract: Disclosure provides RNA molecules comprising a guide sequence portion having 17-50 contiguous nucleotides in the sequence set forth in any one of SEQ ID NOs: 1-7,046 and compositions, methods, and uses thereof. Specifically, the disclosure provides a method for modifying in a cell an allele of the Complement component 3 (C3) gene, the method comprising introducing to the cell a composition comprising: at least one nuclease and a RNA molecule comprising a guide sequence having 17-50 nucleotides provided.
Patent AU-2022242818-A1 (AU)
Title: Pyrazolylpyrimidines for treating malignant solid tumor
Inventor: CHAN KYLE W H
IPC: A61K31/506
Filed: 2022-03-23
Abstract: Provided herein is a method of treating, preventing, or ameliorating one or more symptoms of a malignant solid tumor with a pyrazolylpyrimidine, e.g., a compound of Formula (I), or an enantiomer, a mixture of enantiomers, a diastereomer, a mixture of two or more diastereomers, a tautomer, a mixture of two or more tautomers, or an isotopic variant thereof; or a pharmaceutically acceptable salt, solvate, hydrate, or prodrug thereof.
Patent AU-2022245253-A1 (AU)
Title: An inhaler monitoring device
Inventor: MCDAID LIAM
IPC: A61M11/00
Filed: 2022-03-23
Abstract: An inhaler monitoring device comprising a body comprising an inlet and an outlet which are in fluid communication with respect to one another to define a channel there between, wherein the inlet is for coupling to an inhaler for dispensing a medication and the outlet is for coupling to a spacer having a mouthpiece through which a user can inhale the 5 dispensed medication from the inhaler, one or more sensors which are configured to measure one or more inhalation characteristics when the user inhales the dispensed medication from the inhaler through the inhaler monitoring device via the spacer in-use and processing means which is configured to determine feedback information based on one or more of the inhalation characteristics of the user and supplementary data. Processing 10 means may comprise a central server, and other computing devices, configured using AI techniques to consolidate information provided by the inhaler monitoring device with supplemental data to determine an advisory action to users or other third parties. Additionally, processing means may comprise a data processor in the data capture device where inhalation data and other compliance measurements are used to determine the 15 relaxing or constraining of thresholds of acceptable performance as a way of personalising the use to encourage engagement with a user's medication regime.
Patent AU-2022258350-A1 (AU)
Title: Control display method and apparatus, and electronic device and storage medium
Inventor: YUAN FENGBO
IPC: G06F3/0484
Filed: 2022-04-12
Abstract: Provided in the embodiments of the present disclosure are a control display method and apparatus, and an electronic device and a storage medium. The method comprises: displaying a video playing page, wherein a target video picture of the currently played video and at least one control area are displayed on the video playing page, the at least one control area being located on an upper layer of the target video picture and being used for displaying at least one interactive control of the currently played video; receiving a target sliding operation which acts on the video playing page; and in response to the target sliding operation, controlling the target video picture to move in the sliding direction of the target sliding operation, and adjusting the degree of shielding of the at least one interactive control for the target video picture.
Patent AU-2022258723-A1 (AU)
Title: Cloud-native content management system
Inventor: MARMANIS HARALAMBOS
IPC: G06F21/62
Filed: 2022-04-15
Abstract: A cloud-native content management system includes a content file system for storing digital content to be accessed via the Internet using a compute device. The system includes an authentication and authorization service that applies rules of granular access controls among a group of specified individuals. Using a token-based, temporary access process, authorized individuals are provided direct access to selected digital content in order to bypass time-restriction limitations that traditionally prevent the streaming of large data files. The system is additionally designed to support the interactive, online editing of stored software models by authorized users. As part of the modeling process, model change requests are submitted by authorized individuals using user-intuitive, domain-specific language. Thereafter, the software model is temporarily locked while the change request is validated for correctness and compatibility. Utilizing a staged modeling approach ensures that the software model remains continuously active and allows for granular model versioning.
Patent AU-2022263496-A1 (AU)
Title: Bendamustine Pharmaceutical Compositions
Inventor: VOUDOURIS VASILIOS
IPC: A01N43/52
Filed: 2022-11-02
Abstract: Provided herein are pharmaceutical formulations of dry-powder bendamustine 
suitable for pharmaceutical use. Also 0 provided are methods of producing dry
powder bendamustine. The pharmaceutical formulations can be used for any 
disease that is sensitive to treatment with bendamustine, such as neoplastic 
diseases.
Patent AU-2022267804-A1 (AU)
Title: New anti-muc1 cars and gene edited immune cells for solid tumors cancer immunotherapy
Inventor: ARANDA-ORGILLES BEATRIZ
IPC: C07K16/30
Filed: 2022-04-29
Abstract: The present invention relates to genetically engineered immune cells expressing new anti-MUC1 chimeric antigen receptors and their use in the treatment of solid tumors, particularly suited for allogeneic cell immunotherapy.
Patent AU-2022268344-A1 (AU)
Title: System and method for cultivating biological organisms
Inventor: MCGREGOR COLIN JAMES
IPC: A01G33/00
Filed: 2022-11-09
Abstract: A flow passage (70) is shown in the form of two successively linked, substantially parallel, adjacent, 
open top channels (12A, 14A) to form part of an algae cultivation system. The forward flow of the 
water passes in sequence through the respective open top channels (12A) and (14A) of flow passage 
(70), in the direction of arrow 'A' and then is then recirculated back into to the channel (12A), and so 
on. The combination of added nutrients, sunlight and agitation of the fluid flow encourages the 
growth cultivation of the biological organisms which are continually suspended in the flowing water.  
Such a flow passage (70) can be used as a standalone passage used as part of a system for cultivation 
of biological organisms, or it can also form one basic unit of a modular system which is arranged in 
use to have several such flow passages linked together in use. Such a reconfigurable apparatus gives 
the user the flexibility to cultivate different algae products both separately and simultaneously.
Patent AU-2022269018-A1 (AU)
Title: Water-dispersible article including water-dispersible core construction
Inventor: KNIGHT JONATHON
IPC: C11D17/04
Filed: 2022-05-06
Abstract: An article for cleaning or hand-washing an object includes a core substrate comprising a plurality of fibers including a resin. The core substrate has one or more abrasive surfaces and contains an active cleaning formulation. The resin and the core substrate are water-dispersible upon contact with water at a low temperature, such as 40°C or below, and water-soluble upon contact with water at a higher temperature.
Patent AU-2022272580-A1 (AU)
Title: Anesthetic tunneling tool
Inventor: HEASMAN JOHN MICHAEL
IPC: A61M25/01
Filed: 2022-05-11
Abstract: A surgical tunneling tool and a method of using the surgical tunneling tool are disclosed. In one embodiment, the surgical tunneling tool includes a flexible shaft including a lumen through which an anesthetic may be delivered subcutaneously. In another embodiment, the surgical tunneling tool includes a sheath disposed on a flexible shaft, the sheath including at least one channel through which an anesthetic may be delivered subcutaneously. The subcutaneous distribution of anesthetic may involve stepwise insertion of the surgical tunneling tool. The surgical tunneling tool may be used for insertion of a medical device into a patient after use of the surgical tunneling tool to anesthetize a subcutaneous pathway for the medical device.
Patent AU-2022279242-A1 (AU)
Title: Techniques for placing implantable electrodes to treat sleep apnea, and associated systems
Inventor: O'CONNOR RICHARD
IPC: A61K38/16
Filed: 2022-05-19
Abstract: Techniques for placing implantable electrodes to treat sleep apnea, and associated devices, systems, and methods are disclosed herein. A representative method includes percutaneously implanting one or more signal delivery devices, each at or near a respective target signal delivery location in a patient. Each signal delivery device can include one or more electrodes, and individual ones of the electrodes can be positioned to produce a net positive protrusive motor response of the patient's tongue. The representative method further includes providing power to one or more of the electrodes from a wearable power source to cause the electrode(s) to deliver an electrical signal to the respective target signal delivery location(s) to produce the net positive protrusive motor response.
Patent AU-2022308265-A1 (AU)
Title: Solution for cell manipulation, cell cryopreservation method, and cell thawing method
Inventor: KUWAYAMA MASASHIGE
IPC: C12N5/00
Filed: 2022-07-04
Abstract: Provided are a solution for cell manipulation that improves cell manipulability, and a cell cryopreservation method and cell thawing method that use the solution for cell manipulation. This solution for cell manipulation is to be used for vitrification freezing of cells or thawing of vitrified frozen cells, and contains a thickener. The thickener includes at least one selected from among xanthan gum, carrageenan, gellan gum, locust bean gum, guar gum, and Daiyutan gum. Using the solution for cell manipulation improves cell manipulability in vitrification freezing of cells or thawing of vitrified frozen cells.
Patent AU-2023200696-A1 (AU)
Title: Architectural covering and method of manufacturing
Inventor: COLSON WENDELL B
IPC: E06B9/15
Filed: 2023-02-09
Abstract: An architectural covering and a method of manufacturing the covering is provided. The 
panel may include multiple strips of material extending lengthwise across a width dimension of 
the panel. The strips of material may be overlapped and coupled to one another to define cells 
between adjacent strips of material. The panel may be retracted and extended across an 
architectural opening, and the strips of material may include a resilient support member to 
expand the cells as the panel is extended across the architectural opening. The panel may be 
manufactured by helically winding a continuous, elongate strip of material about a drum in an 
overlapped manner.  
FIG 1
1/16 
100 
1103 
102 106 
FIG.1
Patent AU-2023201737-A1 (AU)
Title: Method and apparatus for video coding
Inventor: LI GUICHUN
IPC: H04N19/543
Filed: 2023-03-21
Abstract: OF THE DISCLOSURE 
A method of video coding, performed by a video encoder. The method comprising: 
determining a picture level syntax element indicating whether a prediction refinement with 
optical flow (PROF) for affine prediction is disabled for a current picture based on whether to 
apply the PROF for affine prediction to an affine coded block in the current picture; where 
responsive to not applying the PROF for affine prediction to the affine coded block in the current 
picture, the picture level syntax element indicates that the PROF for affine prediction is disabled 
for the current picture; and where responsive to applying the PROF for affine prediction to the 
affine coded block in the current picture, the picture level syntax element indicates that the 
PROF for affine prediction is not disabled for the current picture
Patent AU-2023201761-A1 (AU)
Title: A scalable configurable universal full spectrum cyber process that utilises measure points from sensor observation-derived representations or analytically rich sparse data sets for making cyber determinations regarding or utilising sensor observations or sensor observations subjects
Inventor: ARONSON JEFFRY DAVID
IPC: H04L67/01
Filed: 2023-03-21
Abstract: A scalable configurable universal full spectrum cyber process that utilises measure 
points from sensor observation-derived representations or analytically rich sparse data 
sets for making selected cyber determinations regarding or utilising sensor observations 
or sensor observation subjects. Utilising necessary cyber resources and predetermined 
criteria for making selected cyber determinations regarding or utilising the sensor 
observation or at least one sensor observation subject, the disclosed cyber process 
employs the use of measure points for accurately or reliably locating selected 
analytically rich indicators from sensor observation-derived representations, wherein 
appropriate informational representations or measurements regarding or utilising the 
selected analytically rich indicators, the measure points or the sensor observation are 
assigned and stored in analytically rich sparse data sets where they may be utilised by 
the cyber process for making, in real time or at any time thereafter, selected cyber 
determinations regarding or utilising sensor observations or sensor observation 
subjects.
Patent AU-2023202545-A1 (AU)
Title: Pharmaceutical compositions comprising meloxicam
Inventor: TABUTEAU HERRIOT
IPC: A61K47/40
Filed: 2023-04-27
Abstract: The present invention relates to the use of an oral medicament for treating acute migraine comprising the 
steps of selecting a human migraine patient with a history of inadequate response to prior acute migraine 
treatments and an mTOQ-4 score of 7 or less, and orally administering the medicament to the human 
migraine patient; wherein the medicament comprises a combination of a meloxicam and a rizatriptan, Said 
composition may further comprise a bicarbonate (especially sodium carbonate) and sulfobutyl ether beta
cyclodextrin (SBEpCD).
Patent AU-2023203360-A1 (AU)
Title: Multi-nodal supply chain system and method for supply chain workflow execution using transportable and continuously trackable storage bins
Inventor: GRAVELLE SCOTT
IPC: G06Q10/08
Filed: 2023-05-30
Abstract: A multi-nodal supply chain system including multiple interconnected entities and a method for 
executing a supply chain workflow using transportable and continuously trackable, 
standardized storage bins is provided. The entities include a network of node facilities 
distributed throughout a geographical region, inter-nodal transport vehicles (INTVs), storage 
bins storable in indexed storage locations within the node facilities and the INTVs, and a 
computerized system. The computerized system stores bin identifiers of the storage bins and 
location identifiers of the indexed storage locations and dynamic storage locations of the 
storage bins. The computerized system also updates the location identifiers as the storage bins 
are transferred between the node facilities and the INTVs. The node facilities, the INTVs, and 
the storage bins, in communication with the computerized system, provide a complete 
traceability of one or more beaches of inventory items from their input into the supply chain 
system to fulfillment of orders.